drugset / Trial / NCT01088594

A Methodological Study To Evaluate The Effects of Single Oral Doses Of Pioglitazone 45 mg And Rosiglitazone 8 mg On Sodium Balance In Healthy Male Volunteers

NCT01088594

Phase 1 Completed 12 enrolled Solvay Pharmaceuticals
RandomizedCrossoverOpen-label

Summary

A single centre, open, randomized, placebo controlled, 3 period cross-over study to evaluate the effects of single oral doses of pioglitazone 45mg, rosiglitazone 8mg and placebo on urinary sodium excretion in 12 healthy male volunteers

Timeline

Start
2010-02
Primary completion
2010-03
Completion
2010-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Pioglitazone Small molecule 45 mg Oral
Subject Rosiglitazone Small molecule 8 mg Oral